MedPath

Study to assess effects of nano ozonised hydrogen peroxide nebulisation on results of RT-PCR for novel corona Virus thus infectivity and clinical course among mild to moderate sick COVID-19 Patients

Phase 3
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/08/027038
Lead Sponsor
SN medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All newly diagnosed patients

Not requiring mechanical ventilation

on oxygen therapy

Tolerating hydrogen peroxide nebuliser

Consenting patients

On same treatment protocol

Exclusion Criteria

Patients not giving consent

Patient not tolerating nebulization

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of patients who turned negative on RT-PCR for for nCOV for two consecutive days.Timepoint: 6 month
Secondary Outcome Measures
NameTimeMethod
Worsening of patient who turned negative on RT-PCR for nCoV for two consecutive days Patients remain positive even after 5 days of adequate nebulisation Patients showing any manifestation of ADR to izonized hydrogen peroxide.Timepoint: 6 MONTH
© Copyright 2025. All Rights Reserved by MedPath